Sodium alendronate hydrate
PubChem Notes:
Alendronate A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
Molecular Formula:
C4H18NNaO10P2
InChI: InChI=1/C4H13NO7P2.Na.3H2O/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;;;;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);;3*1H2/q;+1;;;/p-1/fC4H12NO7P2.Na.3H2O/h7-8,10H;;;;/q-1;m;;;
InChIKey: InChIKey=DCSBSVSZJRSITC-CBOPLROHCH
SMILES: C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.O.O.O.[Na+]
Names:
Adronat
Alendronate sodium hydrate
Alendronate sodium [USAN]
ALENDRONATE SODIUM
Alendronic acid monosodium salt trihydrate
Alendros
Dronal
Elandor
Fosalan
Sodium alendronate hydrate
sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)butyl]phosphonic acid trihydrate
Registries:
PubChem CID 60736
PubChem ID 196991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|